Dave Toole - Lifevantage Independent Director
LFVN Stock | USD 6.19 0.05 0.80% |
Director
Mr. Dave Toole is Independent Director of the Company. Mr. Toole brings over 35 years of experience as a supply chain digital media and video expert and was the chief executive officer of MediaMobz a private company that enables brands to increase their capacity to create video centric digital media that drives business results since 2008. Mr. Toole is also currently the chief executive officer of Outhink Media an emerging media incubator which position he has held since 2001. Prior to Outhink Media Mr. Toole spent 21 years at GaSonics International a semiconductor capital equipment company where he worked in various positions including as chief executive officer from 1993 to 2001. As chief executive officer at GaSonics Mr. Toole led the company initial public offering in 1994 and the sale of the company to Novellus Systems in 2001. Mr. Toole began his career at Advance Micro Devices a manufacturer of early computer chips where he was a production supervisor from 1976 to 1979 since 2016.
Age | 59 |
Tenure | 8 years |
Phone | 801 432 9000 |
Web | https://www.lifevantage.com |
Lifevantage Management Efficiency
The company has return on total asset (ROA) of 0.0392 % which means that it generated a profit of $0.0392 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1 %, meaning that it created $0.1 on every $100 dollars invested by stockholders. Lifevantage's management efficiency ratios could be used to measure how well Lifevantage manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Jeffrey Watkins | Natures Sunshine Products | 53 | |
Andrew Woeber | Central Garden Pet | 49 | |
Christopher Teets | Natures Sunshine Products | 44 | |
Peter Stanley | J J Snack | 75 | |
Michael Edwards | Central Garden Pet | 57 | |
Daniel Dwyer | Coffee Holding Co | 58 | |
Kathryn Boor | Seneca Foods Corp | 59 | |
Peter Call | Seneca Foods Corp | 61 | |
John Balousek | Central Garden Pet | 72 | |
Michael Edwards | Central Garden Pet | 57 | |
Gregory Scott | Bridgford Foods | 61 | |
Arthur Baer | Seneca Foods Corp | 68 | |
Susan Stuart | Seneca Foods Corp | 62 | |
Gregory Flack | Aryzta AG PK | 53 | |
Travis Robbins | Bridgford Foods | N/A | |
Rebecca Steinfort | Natures Sunshine Products | 45 | |
Todd Andrews | Bridgford Foods | 52 | |
George Sent | Lifeway Foods | 46 | |
Thomas Paulson | Seneca Foods Corp | 61 | |
John Hanson | Central Garden Pet | 58 | |
Mariano Lozano | Lifeway Foods | 47 |
Management Performance
Return On Equity | 0.1 | ||||
Return On Asset | 0.0392 |
Lifevantage Leadership Team
Elected by the shareholders, the Lifevantage's board of directors comprises two types of representatives: Lifevantage inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lifevantage. The board's role is to monitor Lifevantage's management team and ensure that shareholders' interests are well served. Lifevantage's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lifevantage's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carl Aure, Chief Officer | ||
Justin Rose, Chief Sales Officer | ||
Courtland Pearson, Senior Vice President of International | ||
Garry Mauro, Independent Director | ||
Michelle ObornVirchow, Vice President - Human Resources | ||
Vinayak Hegde, Director | ||
George Metzger, Independent Director | ||
Calli Mott, Senior Experience | ||
Chris Taylor, Director Communications | ||
Darwin Lewis, Director | ||
Gary Koos, Interim CFO | ||
Raymond Greer, Director | ||
Kevin McMurray, General Counsel | ||
Richard Okumoto, Independent Director | ||
Darren Jensen, CEO and President and Director | ||
Dave Fleming, VP Sales | ||
Ryan Thompson, Sr. VP of Sales | ||
Steven Fife, CEO President | ||
Julie Boyster, Chief Officer | ||
Ryan Goodwin, Chief Marketing Officer | ||
Kristen Cunningham, Chief Officer | ||
David Manovich, Executive Vice Chairman | ||
Dave Toole, Independent Director | ||
Eric Marchant, Vice Compliance | ||
Robert Urban, COO | ||
David Toole, Independent Director | ||
Alissa Neufeld, General Secretary | ||
Charles Wach, COO | ||
Eiichi Shiokawa, Managing Japan | ||
Mark Jaggi, CFO and Treasurer | ||
Matthew Cooley, Chief Officer | ||
Michael Beindorff, Independent Director |
Lifevantage Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lifevantage a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.1 | ||||
Return On Asset | 0.0392 | ||||
Profit Margin | 0.01 % | ||||
Operating Margin | (0.02) % | ||||
Current Valuation | 76.04 M | ||||
Shares Outstanding | 12.87 M | ||||
Shares Owned By Insiders | 16.34 % | ||||
Shares Owned By Institutions | 28.77 % | ||||
Number Of Shares Shorted | 67.57 K | ||||
Price To Earning | 4.65 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifevantage. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Lifevantage Stock, please use our How to Invest in Lifevantage guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Lifevantage Stock analysis
When running Lifevantage's price analysis, check to measure Lifevantage's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifevantage is operating at the current time. Most of Lifevantage's value examination focuses on studying past and present price action to predict the probability of Lifevantage's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifevantage's price. Additionally, you may evaluate how the addition of Lifevantage to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Lifevantage's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifevantage. If investors know Lifevantage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifevantage listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lifevantage is measured differently than its book value, which is the value of Lifevantage that is recorded on the company's balance sheet. Investors also form their own opinion of Lifevantage's value that differs from its market value or its book value, called intrinsic value, which is Lifevantage's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifevantage's market value can be influenced by many factors that don't directly affect Lifevantage's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifevantage's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifevantage is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifevantage's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.